Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia

BACKGROUND: Preliminary data from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia patients indicate that a cytokine storm may increase morbidity and mortality. Tocilizumab (anti-IL-6R) is approved by the Food and Drug Administration for treatment of cytokine storm associated w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Infect Dis
Hlavní autoři: Jordan, Stanley C, Zakowski, Phillip, Tran, Hai P, Smith, Ethan A, Gaultier, Cyril, Marks, Gregory, Zabner, Rachel, Lowenstein, Hayden, Oft, Jillian, Bluen, Benjamin, Le, Catherine, Shane, Rita, Ammerman, Noriko, Vo, Ashley, Chen, Peter, Kumar, Sanjeev, Toyoda, Mieko, Ge, Shili, Huang, Edmund
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Major Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7337689/
https://ncbi.nlm.nih.gov/pubmed/32575124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa812
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky